All adults with Down syndrome over 35-40 years of age develop the characteristic Alzheimer’s neuropathology, including the formation of beta-amyloid plaques, with earlier onset of dementia developing in more than 70% of individuals. Read more from a Science Daily article and review the connections to the greater Alzheimer’s community.
DS Connect is a secure centralized information clearinghouse funded and launched by NIH. It is a resource for communication among families, researchers, clinicians, and patient groups, and will be an essential tool in supporting new clinical studies and trials to benefit people with Ds. To learn more about the registry, download DS-Connect’s informational flyer or visit …
A newly published study funded in part by DSRTF shows that an asthma drug already in use improves cognitive function in a mouse model of DS.
We know the urgency of helping people with DS build a future in which their promise can be fulfilled. This month we take that message worldwide.
“What is it about learning and memory that’s dependent on a particular time of day?” Dr. Heller expounded on this and other questions in cognition research during January’s webinar.